AI assistant
Moderna, Inc. — Director's Dealing 2020
Jun 18, 2020
30610_dirs_2020-06-18_c31da7fa-777a-4f83-bce6-744588bf3585.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-06-16
Reporting Person: Zaks Tal Zvi (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-06-16 | Common Stock | M | 24121 | $19.15 | Acquired | 24121 | Direct |
| 2020-06-16 | Common Stock | M | 15631 | $19.15 | Acquired | 39752 | Direct |
| 2020-06-16 | Common Stock | S | 22132 | $63.40 | Disposed | 17620 | Direct |
| 2020-06-16 | Common Stock | S | 16320 | $64.08 | Disposed | 1300 | Direct |
| 2020-06-16 | Common Stock | S | 1000 | $65.69 | Disposed | 300 | Direct |
| 2020-06-16 | Common Stock | S | 300 | $66.58 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-06-16 | Stock Option (Right to Buy) | $19.15 | M | 24121 | Disposed | 2026-08-10 | Common Stock (24121) | Direct |
| 2020-06-16 | Stock Option (Right to Buy) | $19.15 | M | 15631 | Disposed | 2026-08-10 | Common Stock (15631) | Direct |
Footnotes
F1: The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.
F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $62.82 to $63.82. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.83 to $64.75. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $65.49 to $65.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F5: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $66.57 to $66.58. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F6: This option is fully vested and exercisable.